ANDROCUR

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug ANDROCUR contains one active pharmaceutical ingredient (API):

1 Cyproterone
UNII 4KM2BN5JHF - CYPROTERONE ACETATE

Cyproterone acetate acts as an antiandrogen by blocking androgen receptors. It also has progestogenic activity, which exerts a negative feedback effect on hypothalamic receptors, so leading to a reduction in gonadotrophin release, and hence to diminished production of testicular androgens. Sexual drive and potency are reduced and gonadal function is inhibited.

Read about Cyproterone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ANDROCUR Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ANDROCUR Tablet / Solution for injection Health Products and Food Branch (CA) MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03HA01 Cyproterone G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03H Antiandrogens → G03HA Antiandrogens, plain
Discover more medicines within G03HA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1270W, 8019C
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 538912050012813, 538912050012913
Country: CA Health Products and Food Branch Identifier(s): 00704423, 00704431
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00928110, 01551015, 02454691, 02474825, 02579062, 03293416, 03415902, 03903317, 03967760, 04419345, 04456139, 04522155, 04690160, 04690177, 04954765, 04954771, 07432180, 07663583, 08853245, 09760020, 10546591, 12725381, 16749533
Country: EE Ravimiamet Identifier(s): 1064124
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 52691
Country: FR Base de données publique des médicaments Identifier(s): 61255738
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 105156, 343427
Country: HK Department of Health Drug Office Identifier(s): 46443
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-843981106
Country: IE Health Products Regulatory Authority Identifier(s): 14194
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4645, 8
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1000129
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 341M79
Country: NL Z-Index G-Standaard, PRK Identifier(s): 17302, 2712
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100004443
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64041001, W64041002
Country: SG Health Sciences Authority Identifier(s): 04639P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 17463021
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699546011667, 8699546013838
Country: ZA Health Products Regulatory Authority Identifier(s): 29/21.12/0515, R/21.12/159, R/21.12/160

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.